CPHA Canvax

"Health Canada has conducted a rigorous scientific review of the available scientific evidence to assess the safety, efficacy and quality of the Pfizer-BioNTech COVID-19 vaccine. No major safety concerns have been identified. Based on the current information, Health Canada has assessed that this vaccine’s benefits outweigh its risks." - Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies 


Web link

Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies

Related Resources

Bookmark

Implementation Tool

Link

Category

Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Storage and Handling,Allocation and Distribution,Vaccine Safety and Development,Vaccine Safety,Vaccine Safety,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Management
Storage and Handling
Allocation and Distribution
Vaccine Safety and Development
Vaccine Safety
Vaccine Safety
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.